Lihteh WuJ. Fernando ArévaloErick Hernández-BogantesJosé A. Roca2026-03-222026-03-22201210.1007/s10792-012-9559-8https://doi.org/10.1007/s10792-012-9559-8https://andeanlibrary.org/handle/123456789/44826Citaciones: 42enMacular edemaMedicineInfliximabRefractory (planetary science)OphthalmologyUveitisVisual acuityAdverse effectRetrospective cohort studyTumor necrosis factor alphaIntravitreal infliximab for refractory pseudophakic cystoid macular edema: results of the Pan-American Collaborative Retina Study Grouparticle